EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vitamin D 3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing

Souraya Sayegh iD, Carlos Henrique Fantecelle, Phatthamon Laphanuwat, Priya Subramanian, Malcom H A Rustin, Daniel C O Gomes, Arne N Akbar iD, Emma S Chambers iD

Aging Cell · 2024-04 · 23 (4)

DOI: 10.1111/acel.14093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, online erschienen am 29.01.2024. Verfasst von Souraya Sayegh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicine, University College London, London, UK. Hauptthemen laut MEDLINE: Cellular Senescence, Cholecalciferol. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, MRF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitamin D 3 replacement in older insufficient adults significantly improves their antigen‐specific varicella zoster virus (VZV) cutaneous immunity. However, the mechanisms involved in this enhancement of cutaneous immunity are not known. Here, we show for the first time that vitamin D 3 blocks the senescence‐associated secretory phenotype (SASP) production by senescent fibroblasts by partially inhibiting the p38 MAPK pathway. Furthermore, transcriptomic analysis of skin biopsies from older subjects after vitamin D 3 supplementation shows that vitamin D 3 inhibits the same inflammatory pathways in response to saline as the specific p38 inhibitor, losmapimod, which also enhances immunity in the skin of older subjects. Vitamin D 3 supplementation therefore may enhance immunity during ageing in part by blocking p38 MAPK signalling and in turn inhibit SASP production from senescent cells in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceCholecalciferolAdultHumansAgedp38 Mitogen-Activated Protein KinasesAgingFibroblastsInflammation MediatorsImmunity

Stichwörter der Autor:innen

SASPageingp38 MAPKsenescenceskinvitamin D

Substanzen

Cholecalciferolp38 Mitogen-Activated Protein KinasesInflammation Mediators

Autor:innen und Institutionen

  • Division of Medicine, University College London, London, UK.
  • Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitoria, Brazil.
  • Department of Dermatology, Royal Free Hospital, London, UK.
  • Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, UK.

ORCID-Profile: Souraya Sayegh, Arne N Akbar, Emma S Chambers

Förderung

  • Wellcome Trust
  • Medical Research Council
  • MRF
  • LEO Fondet
  • Medical Research Foundation
  • British Skin Foundation
  • Barts Charity

Zitieren

APA

Sayegh, S., Fantecelle, C. H., Laphanuwat, P., Subramanian, P., Rustin, M. H. A., Gomes, D. C. O., Akbar, A. N., & Chambers, E. S. (2024). Vitamin D 3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing. Aging Cell, 23(4). https://doi.org/10.1111/acel.14093

Vancouver

Sayegh S, Fantecelle CH, Laphanuwat P, Subramanian P, Rustin MHA, Gomes DCO, et al. Vitamin D 3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing. Aging Cell. 2024;23(4). doi:10.1111/acel.14093

BibTeX
@article{Sayegh2024,
  author = {Sayegh, Souraya and Fantecelle, Carlos Henrique and Laphanuwat, Phatthamon and Subramanian, Priya and Rustin, Malcom H A and Gomes, Daniel C O and Akbar, Arne N and Chambers, Emma S},
  title = {Vitamin D 3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing},
  journal = {Aging Cell},
  year = {2024},
  volume = {23},
  number = {4},
  doi = {10.1111/acel.14093}
}
Kostenlos starten →